Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
Ryuichi WasedaThomas KlikovitsMir Alireza HodaKonrad HoetzeneckerPietro BertoglioKarin DieckmannSabine Zöchbauer-MüllerRobert PirkerHelmut ProschBalazs DömeWalter KlepetkoPublished in: Journal of surgical oncology (2017)
Trimodality treatment including radical resection for Pancoast tumors provides good surgical outcome and favorable long-term results. Survival of patients with T4 tumors and extended surgical procedures comparable to that of patients with T3 tumors undergoing rib resection only.